Literature DB >> 18977616

Experimental infection of SPF pigs with Actinobacillus pleuropneumoniae serotype 9 alone or in association with Mycoplasma hyopneumoniae.

Corinne Marois1, Marcelo Gottschalk, Hervé Morvan, Christelle Fablet, François Madec, Marylène Kobisch.   

Abstract

The purpose of this study was to compare in SPF pigs, the pathogenicity of an Actinobacillus pleuropneumoniae serotype 9 strain 21 (isolated from the palatine tonsils of a healthy gilt on a French nucleus pig farm, with no clinical signs or lung lesions but a highly positive reaction to A. pleuropneumoniae serotype 9 antibodies) with a pathogenic A. pleuropneumoniae strain 4915 serotype 9 (isolated in France from an outbreak of porcine pleuropneumonia). The pathogenicity of one Mycoplasma hyopneumoniae strain alone or associated with A. pleuropneumoniae strain 21 was also compared. Eight groups of 7 pigs were infected (at 6 or 10 weeks of age) and a control group was kept non-infected. Results showed that sensitivity to A. pleuropneumoniae was related to the age of the pig (6 weeks vs 10 weeks) whatever the strain. Surviving pigs infected at 6 weeks of age developed severe clinical signs, lung lesions typical of A. pleuropneumoniae and they seroconverted. In contrast, symptoms and lung lesions were almost non-existent in pigs infected with strain 21 at 10 weeks of age, but a seroconversion was observed with very high ELISA titres. These results were in accordance with those observed in the nucleus pig farm. Infection with M. hyopneumoniae alone induced typical mycoplasmal symptoms, pneumonia and seroconversion. Symptoms and lung lesions were the most noticeable in pigs infected with M. hyopneumoniae at 6 weeks of age and with A. pleuropneumoniae 4 weeks later. Our results show that the presence of A. pleuropneumoniae serotype 9 in a pig herd may be clinically unnoticed and that M. hyopneumoniae may potentiate A. pleuropneumoniae infection.

Entities:  

Mesh:

Year:  2008        PMID: 18977616     DOI: 10.1016/j.vetmic.2008.09.061

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  10 in total

1.  The role of co-infections in M. hyopneumoniae outbreaks among heavy fattening pigs: a field study.

Authors:  Matteo Tonni; Nicoletta Formenti; M Beatrice Boniotti; Flavia Guarneri; Federico Scali; Claudia Romeo; Paolo Pasquali; Maria Pieters; Dominiek Maes; Giovanni L Alborali
Journal:  Vet Res       Date:  2022-06-13       Impact factor: 3.829

2.  A total infectome approach to understand the etiology of infectious disease in pigs.

Authors:  Xinyi Huang; Weichen Wu; Xiaoxiao Tian; Xin Hou; Xingyang Cui; Yihong Xiao; Qiulin Jiao; Pei Zhou; Liqiang Liu; Weilin Shi; Ligong Chen; Yue Sun; Yongbo Yang; Jianxin Chen; Guihong Zhang; Jinling Liu; Edward C Holmes; Xuehui Cai; Tongqing An; Mang Shi
Journal:  Microbiome       Date:  2022-05-10       Impact factor: 16.837

Review 3.  Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host.

Authors:  Koen Chiers; Tine De Waele; Frank Pasmans; Richard Ducatelle; Freddy Haesebrouck
Journal:  Vet Res       Date:  2010-06-15       Impact factor: 3.683

4.  Detection of Actinobacillus Pleuropneumoniae ApxIV Toxin Antibody in Serum and Oral Fluid Specimens from Pigs Inoculated Under Experimental Conditions.

Authors:  Wendy González; Luis G Giménez-Lirola; Ashley Holmes; Sergio Lizano; Christa Goodell; Korakrit Poonsuk; Panchan Sitthicharoenchai; Yaxuan Sun; Jeffrey Zimmerman
Journal:  J Vet Res       Date:  2017-12-06       Impact factor: 1.744

5.  Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants.

Authors:  Xirui Xia; Lan Yang; Yuzhou Ling; Jiao Yu; Huanzhong Ding
Journal:  Front Vet Sci       Date:  2022-02-11

6.  Efficacy of Two Commercial Ready-To-Use PCV2 and Mycoplasma hyopneumoniae Vaccines under Field Conditions.

Authors:  Gonzalo López-Lorenzo; Alberto Prieto; Cynthia López-Novo; Pablo Díaz; Ceferino Manuel López; Patrocinio Morrondo; Gonzalo Fernández; José Manuel Díaz-Cao
Journal:  Animals (Basel)       Date:  2021-05-26       Impact factor: 2.752

7.  Association between transmission rate and disease severity for Actinobacillus pleuropneumoniae infection in pigs.

Authors:  Tijs J Tobias; Annemarie Bouma; Angeline J J M Daemen; Jaap A Wagenaar; Arjan Stegeman; Don Klinkenberg
Journal:  Vet Res       Date:  2013-01-11       Impact factor: 3.683

8.  Analysis of the mutant selection window and killing of Mycoplasma hyopneumoniae for doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin.

Authors:  Zilong Huang; Chunxiao Mao; Yanzhe Wei; Xiaoyan Gu; Qinren Cai; Xiangguang Shen; Huanzhong Ding
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

9.  Performance of Commercial Mycoplasma hyopneumoniae Serum Enzyme-Linked Immunosorbent Assays under Experimental and Field Conditions.

Authors:  Ana Paula S Poeta Silva; Ronaldo L Magtoto; Henrique M Souza Almeida; Aric McDaniel; Precy D Magtoto; Rachel J Derscheid; Maria M Merodio; Franco S Matias Ferreyra; Igor R H Gatto; David H Baum; Maria J Clavijo; Bailey L Arruda; Jeffrey J Zimmerman; Luis G Giménez-Lirola
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

Review 10.  Genomic Variability and Post-translational Protein Processing Enhance the Immune Evasion of Mycoplasma hyopneumoniae and Its Interaction With the Porcine Immune System.

Authors:  Gaojian Li; Enoch Obeng; Jinqi Shu; Jianhong Shu; Jian Chen; Yuehong Wu; Yulong He
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.